• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tilray Brands Inc (NQ: TLRY )

    1.640 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Tilray Brands Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls & Vapes As Market Eyes C$5.47B
    The Canadian cannabis market is shifting towards newer product formats, with some segments outperforming cannabis flowers in sales. 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
    Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday. 
    Via Benzinga
    Topics Cannabis Government
    Exposures Cannabis Political
    Canadian Cannabis LP Stocks Portfolio -10% W/e Sept. 6th
    Our LP portfolio was down 10% last week as a result of the August 26th announcement by the DEA that it had scheduled an administrative hearing for December 2nd to consider differing expert opinions on... 
    Via Talk Markets
    Topics Cannabis
    Exposures Cannabis
    Marijuana Stock Movers For September 9, 2024
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
    Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday a new scientific publication supported by Tilray Medical titled, Treatment in... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
    From Tilray Brands, Inc.
    Via GlobeNewswire
    Data Shows More Consumers Opting for Sustainably Manufactured Cannabis Products
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    Our Conservative "Cannabis" Portfolio Performed Better In August (and YTD) Than Either OUR MSO Or LP Portfolios
    If you are wary of the volatility of cannabis stocks then consider the 5 tobacco, beer, and distiller/vintner companies that have major investments in the cannabis sector. Their stock returns... 
    Via Talk Markets
    Topics Cannabis
    Exposures Cannabis
    Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
    Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump's comments on the legalization of marijuana in Florida. 
    Via Benzinga
    Topics Cannabis Government
    Exposures Cannabis Political
    420 with CNW — NIH Study Finds Concurrent Use of Tobacco, Marijuana Is Rising
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    Billion-Dollar Cannabis Company Closes Acquisition Of Three US Breweries, What's Next For Tilray
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company
    From Tilray Brands, Inc.
    Via GlobeNewswire
    Largest Cannabis Stocks Are Down +10% In Last Two Days: Here's Why
    The American Cannabis MSO Portfolio is DOWN 13.2% in the past 2 days and is now DOWN 18.4% MTD (and DOWN 5.9% YTD). 
    Via Talk Markets
    Topics Cannabis
    Exposures Cannabis
    Canopy Growth's CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock?
    A change in CEO could help Canopy Growth pivot away from a costly strategy focused on the U.S. pot market. 
    Via The Motley Fool
    Topics Cannabis
    Exposures Cannabis
    Marijuana Stock Movers For August 27, 2024
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    3 New Reasons to Consider Buying Tilray Brands Stock in 2024
    Its strategic ambitions for its beer business are quickly becoming a reality. 
    Via The Motley Fool
    NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
    The cannabis company on Nasdaq has partnered with Vectura Fertin Pharma, to launch a dissolvable tablet that delivers a precise dose of CBD. 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Breckenridge Brewery Announces Latest Concert Series With Kaleo, Hippo Campus and Cassandra Lewis
    Concert Proceeds to Support Project C.U.R.E. 
    From Tilray Brands, Inc.
    Via GlobeNewswire
    1 Stock I Wouldn't Touch With a 10-Foot Pole
    The stock has been a terrible investment in recent years. 
    Via The Motley Fool
    Tilray Brands Is Buying More Beer Brands, and Its Wheeling and Dealing Isn't Over
    Expanding into alcohol has helped Tilray grow its operations and improve its bottom line. 
    Via The Motley Fool
    420 with CNW — Adolescents Marijuana, Alcohol Use May Be Influenced by Childhood Sleep Patterns
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    Aurora Cannabis Dominates 30% Of Canada's Medical Marijuana Exports: Will Its Bold International Expansion Pay Off?
    Aurora exported C$39.3 million in Medicinal Cannabis. A Wednesday report provides a detailed analysis of the company's financial standing. 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Tilray Is Not Giving Up On Cannabis, Ramps Up Its Canadian Portfolio On Heels Of Buying Four US Breweries
    Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Thursday the release of premium cannabis brand, BROKEN COAST's latest small batch flower strain dubbed 'Milk & Cookies'. The new strain is... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Craft Cannabis Brand, Broken Coast, Launches Latest Artisanal Strain, ‘Milk & Cookies’ for Avid Indica Enthusiasts
    From Tilray Brands, Inc.
    Via GlobeNewswire
    Do These 4 New Moves Make Tilray Brands Stock a Buy?
    Its latest big play in craft beer is likely to be the most financially beneficial. 
    Via The Motley Fool
    Marijuana Stock Movers For August 20, 2024
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Industrial Hemp's $14B Projected Growth: An Investment Opportunity Too Good To Miss
    Discover how investing in industrial hemp can unlock financial opportunities in a growing, sustainable market. 
    Via Benzinga
    Solei Launches New THC Infused Sparkling Beverages and Topicals
    Discover Solei’s Refreshing CBD and CBG ‘Chilled Sips for Self-Care’ Beverages and Wind Down with Solei’s New Extra-Strength Deep Tissue Stick 
    From Tilray Brands, Inc.
    Via GlobeNewswire
    What's Going On With Cannabis Grower Tilray's Stock?
    Tilray shares are trading higher Wednesday. The company announced Tuesday that it will acquire four craft breweries from Molson Coors. Here's what to know: 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.